- Home
- AUUD vs SCNI Comparison
AUUD vs SCNI Comparison
Compare AUUD & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- SCNI
- Stock Information
- Founded
- AUUD 2012
- SCNI 2003
- Country
- AUUD United States
- SCNI Israel
- Employees
- AUUD N/A
- SCNI N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AUUD Technology
- SCNI Health Care
- Exchange
- AUUD Nasdaq
- SCNI Nasdaq
- Market Cap
- AUUD 3.1M
- SCNI 3.5M
- IPO Year
- AUUD 2021
- SCNI N/A
- Fundamental
- Price
- AUUD $0.51
- SCNI $2.84
- Analyst Decision
- AUUD
- SCNI
- Analyst Count
- AUUD 0
- SCNI 0
- Target Price
- AUUD N/A
- SCNI N/A
- AVG Volume (30 Days)
- AUUD 115.3K
- SCNI 12.9K
- Earning Date
- AUUD 11-07-2024
- SCNI 11-29-2024
- Dividend Yield
- AUUD N/A
- SCNI N/A
- EPS Growth
- AUUD N/A
- SCNI N/A
- EPS
- AUUD N/A
- SCNI N/A
- Revenue
- AUUD N/A
- SCNI $284,000.00
- Revenue This Year
- AUUD N/A
- SCNI N/A
- Revenue Next Year
- AUUD N/A
- SCNI N/A
- P/E Ratio
- AUUD N/A
- SCNI N/A
- Revenue Growth
- AUUD N/A
- SCNI N/A
- 52 Week Low
- AUUD $0.48
- SCNI $2.23
- 52 Week High
- AUUD $11.75
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- AUUD 35.17
- SCNI 30.31
- Support Level
- AUUD $0.53
- SCNI $2.91
- Resistance Level
- AUUD $0.61
- SCNI $3.70
- Average True Range (ATR)
- AUUD 0.05
- SCNI 0.21
- MACD
- AUUD -0.00
- SCNI -0.07
- Stochastic Oscillator
- AUUD 16.06
- SCNI 7.37
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products include Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.